SPAIC Oporto 2011

The ideal antihistamine should have the following characteristics:

  • Rapid onset of action (<30 minutes).
  • Long duration of action
  • Powerful antihistaminic effect
  • Anti-inflammatory effects
  • Reliable safety profile

This safety profile includes:

  1. No entry into the brain and no CNS side-effects
  2. High selectivity for the H1 receptor and no cardiac toxicity
  3. No potential for pharmacological interactions
  4. No hepatic metabolism

In vitro binding studies and research in animal tissue have shown the high specificity of bilastine for H1 receptors.

Only registered health professionals are allowed to see the report